Camilla Jessen
There’s an active recall on blood pressure medication prescribed and sold nationwide.
More than 580,000 bottles of a commonly prescribed blood pressure medication have been recalled nationwide due to potential cancer-causing impurities, according to a safety alert issued by the U.S. Food and Drug Administration (FDA).
The recalled drug is Prazosin hydrochloride, which is used to treat high blood pressure (hypertension).
The affected capsules were distributed by Teva Pharmaceuticals USA and sold in 100-, 250-, 500-, and 1,000-count bottles.
What’s the risk?
According to the FDA, the recall was triggered after tests found high levels of “N-nitroso Prazosin impurity C,” a potentially carcinogenic compound.
The impurity exceeded the acceptable safety limits set by the Carcinogenic Potency Categorization Approach (CPCA).
While small amounts of this impurity may pose minimal health risk, long-term exposure above established limits may increase cancer risk.
As a result, the FDA classified this as a Class II recall, meaning the drug could cause temporary or medically reversible health issues.
Affected bottles
The recalled Prazosin hydrochloride capsules have expiration dates from October 2025 through February 2027.
Patients are urged to check the label and bottle size to confirm if their medication is part of the recall.
What you should do
Stop taking the recalled medication and contact your doctor immediately for alternatives.
Return or dispose of the affected product according to the FDA’s medication disposal guidelines.
This article is made and published by Camilla Jessen, who may have used AI in the preparation
